ReviewBiomarker research2022

Combining BTK inhibitors with BCL2 inhibitors for treating chronic lymphocytic leukemia and mantle cell lymphoma.

Jing Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.